BTCRC-GI22-588

A Phase II Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer

Status

Currently Enrolling

Cancer Type(s)

Trial Locations

All sites in which the trial BTCRC-GI22-588 being conducted in.